InvestHK Promotes Hong Kong's Biotech Edge at BIO International Convention 2025

Strategic Insights -

As the global biotech industry converges at the Boston Convention & Exhibition Center from June 16 to 19, a delegation of 16 Hong Kong life science and health technology companies, led by the Hong Kong Government's InvestHK, will showcase the city's cutting-edge biotech ecosystem. This joint effort highlights Hong Kong's strategic strengths as a biotech powerhouse, underscoring the strong partnership between InvestHK and the Hong Kong Science and Technology Parks Corporation (HKSTP) to promote Hong Kong's vibrant biotech ecosystem globally.

Key Takeaways:

  • A delegation of 16 Hong Kong life science and health technology companies, led by InvestHK, will join the BIO International Convention 2025, highlighting Hong Kong's biotech edge.
  • The Hong Kong pavilion will showcase the city's advantages and opportunities for American biotech companies, including a top-tier academic research and talent pool, world-class research and development infrastructure, and robust intellectual property protection.
  • InvestHK will connect with global industry pioneers to share insights and forge partnerships, emphasizing Hong Kong's strategic strengths as a biotech powerhouse.
  • Hong Kong's biotech sector is driven by innovations such as smart hospitals and telehealth, addressing rising healthcare demands with sustainable solutions.
  • The Hong Kong Special Administrative Region Government is enhancing the city's capabilities through the establishment of the InnoLife Healthtech Hub in the Hong Kong-Shenzhen Innovation and Technology Park.
  • The GBA presents significant opportunities for American biotech firms, with designated GBA healthcare institutions able to utilise Hong Kong-registered drugs and medical devices approved for public hospitals.
  • InvestHK has seen strong momentum in attracting innovation and technology (I&T) companies to establish or expand their presence in the city, with 120 I&T companies assisted in 2024, up from 82 in 2023.

Statistics:

  • 16 Hong Kong life science and health technology companies will join the BIO International Convention 2025.
  • The Hong Kong pavilion will connect with over 20,000 global industry leaders at the convention.
  • 51 drugs and 63 medical devices have been allowed by the Guangdong Provincial Medical Products Administration as of April 30, 2025, for use in designated GBA healthcare institutions.
  • InvestHK assisted 120 I&T companies in 2024, up from 82 in 2023, making it the top-performing sector supported by the department.

Sources:

  • Hong Kong Government special administrative region InvestHK promotes Hong Kong's biotech edge at BIO International Convention 2025
  • InnoLife Healthtech Hub in the Hong Kong-Shenzhen Innovation and Technology Park
  • Hong Kong Exchanges and Clearing Limited Listing Rules reform
  • Guangdong Provincial Medical Products Administration
  • InvestHK 2024 Policy Address
  • Hong Kong Science and Technology Parks Corporation (HKSTP)